The U.S. Preventive Task Services (USPSTF) recommendations that women ages 50-74 years undergo biennial screening mammography and women ages 40-49 years make an individual decision regarding screening had little impact on screening mammography use, according to a study published online May 15 in Journal of General Internal Medicine.

Digital mammography and film-screen mammography deliver comparable breast cancer detection performance, but computed radiography (CR) mammography was less likely by 21 percent to help detect breast cancer, according to a study published online May 14 in Radiology.

An analysis published Nov. 22, 2012, in New England Journal of Medicine, that estimated more than 30 percent of all breast cancers diagnosed in 2008 represented overdiagnosis, should be retracted, according to Daniel B. Kopans, MD, director of breast imaging at Massachusetts General Hospital in Boston, in a point-counterpoint exchange published in the May issue of the Journal of American College of Radiology.

Young African American, Hispanic, uninsured, publicly insured and low socioeconomic status women with breast cancer experience delays in treatment and decreased survival time, according to a health disparities study published April 24 in JAMA Surgery.

The U.S. Preventive Services Task Force (USPSTF) screening mammography recommendations revised in 2009 have not been adopted and screening mammography rates have nudged up since 2005, according to a study published April 19 in CANCER.

This week, a single study set my blood boiling. A false-positive screening mammogram was linked with long-term psychosocial harm, trauma and existential crisis, in a study published March 18 in Annals of Family Medicine. Again, I ask, seriously?

A study published March 18 in Annals of Family Medicine that detailed long-term psychosocial harms of false-positive screening mammograms is compromised by methodological irregularities, underplays the harm of a breast cancer diagnosis and does not address existing strategies used to minimize anxiety, according to statements by the American College of Radiology (ACR), the Society of Breast Imaging (SBI) and breast imaging experts.

More than 75 percent of breast tumors showing posterior enhancement on ultrasound imaging were Grade III, and approximately one-third were triple negative, whereas posterior shadowing was strongly associated with an ER-negative and low-grade tumor, researchers reported in a study published in the February issue of American Journal of Roentgenology.